DE69232162D1 - Hapten-Analoge zur Verwendung in Immunoassays - Google Patents

Hapten-Analoge zur Verwendung in Immunoassays

Info

Publication number
DE69232162D1
DE69232162D1 DE69232162T DE69232162T DE69232162D1 DE 69232162 D1 DE69232162 D1 DE 69232162D1 DE 69232162 T DE69232162 T DE 69232162T DE 69232162 T DE69232162 T DE 69232162T DE 69232162 D1 DE69232162 D1 DE 69232162D1
Authority
DE
Germany
Prior art keywords
nucleus
immunoassays
hapten
ester group
drug hapten
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232162T
Other languages
English (en)
Other versions
DE69232162T2 (de
Inventor
Susan Jean Danielson
Marsha D Oenick
Ignazio Ponticello
David Alan Hilborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Johnson and Johnson Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Clinical Diagnostics Inc filed Critical Johnson and Johnson Clinical Diagnostics Inc
Application granted granted Critical
Publication of DE69232162D1 publication Critical patent/DE69232162D1/de
Publication of DE69232162T2 publication Critical patent/DE69232162T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
DE69232162T 1991-06-07 1992-06-02 Hapten-Analoge zur Verwendung in Immunoassays Expired - Lifetime DE69232162T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71232991A 1991-06-07 1991-06-07
US07/851,435 US5284948A (en) 1991-06-07 1992-03-16 Drug hapten analogues for immunoassays

Publications (2)

Publication Number Publication Date
DE69232162D1 true DE69232162D1 (de) 2001-12-06
DE69232162T2 DE69232162T2 (de) 2002-07-11

Family

ID=27108809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232162T Expired - Lifetime DE69232162T2 (de) 1991-06-07 1992-06-02 Hapten-Analoge zur Verwendung in Immunoassays

Country Status (5)

Country Link
US (1) US5284948A (de)
EP (1) EP0517325B1 (de)
JP (1) JP3190728B2 (de)
AT (1) ATE208042T1 (de)
DE (1) DE69232162T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents
BR122014027339B1 (pt) * 2000-01-07 2017-01-17 Monsanto Technology Llc métodos para seleção de planta de soja tendo alelo de rhg4 resistente ao nematódeo do cisto da soja e para investigação de haplótipo de rhg4 de planta de soja, bem como método de seleção assistida por marcador de ácido nucleico em planta de soja para seleção de planta de soja tendo alelo que confere resistência ao nematódeo do cisto da soja
US6991911B2 (en) 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US7022492B2 (en) 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US7037669B2 (en) 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
US7115383B2 (en) 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
US8133743B2 (en) * 2007-10-19 2012-03-13 Roche Diagnostics Operations, Inc. Phenobarbital derivatives useful in immunoassay
CN103364556B (zh) * 2012-04-05 2016-02-24 北京勤邦生物技术有限公司 一种检测呋喃妥因代谢物的试剂盒及方法
CN110003201A (zh) * 2012-08-21 2019-07-12 詹森药业有限公司 帕潘立酮半抗原
KR101515020B1 (ko) 2013-11-13 2015-04-24 에스케이텔레콤 주식회사 햅텐 및 이에 결합하는 항체를 레퍼런스 항체로 이용하는 면역학적 측정 방법 및 상기 레퍼런스 항체를 이용한 면역학적 측정장치
CN110054620B (zh) * 2019-04-19 2021-01-26 北京九强生物技术股份有限公司 一种苯巴比妥衍生物及其在免疫检测中的用途
CN111875587B (zh) * 2020-07-23 2021-07-13 湖南苏阳医疗科技有限公司 5-氟胞嘧啶衍生物、其制备方法及其在5-氟胞嘧啶免疫检测试剂中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065354A (en) * 1974-10-10 1977-12-27 Syva Company Lysozyme conjugates for enzyme immunoassays
US4092479A (en) * 1976-04-05 1978-05-30 Baxter Travenol Laboratories, Inc. Labeled 5,5-diphenylhydantoin derivatives for radioimmunoassay
US4182856A (en) * 1978-04-25 1980-01-08 Miles Laboratories, Inc. Reagents for use in binding assays to determine diphenylhydantoin
US4244939A (en) * 1978-06-12 1981-01-13 Baxter Travenol Laboratories, Inc. Barbituric acid tracers and their preparation
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
NZ199629A (en) * 1981-02-17 1984-11-09 Abbott Lab Fluorescent polarisation immunoassay and certain substituted carboxy fluoresceins
US4670381A (en) * 1985-07-19 1987-06-02 Eastman Kodak Company Heterogeneous immunoassay utilizing horizontal separation in an analytical element
US4752568A (en) * 1986-01-13 1988-06-21 Eastman Kodak Company Labeled hydantoin conjugate and its use in analytical element and immunoassays
ATE154135T1 (de) * 1989-03-10 1997-06-15 Hoffmann La Roche Reagenzien zum nachweis von drogen

Also Published As

Publication number Publication date
ATE208042T1 (de) 2001-11-15
JP3190728B2 (ja) 2001-07-23
US5284948A (en) 1994-02-08
JPH0627107A (ja) 1994-02-04
DE69232162T2 (de) 2002-07-11
EP0517325B1 (de) 2001-10-31
EP0517325A2 (de) 1992-12-09
EP0517325A3 (en) 1993-04-07

Similar Documents

Publication Publication Date Title
DK0672057T3 (da) Analoger af PTH
ATE106401T1 (de) Benzodiazepin-analoge.
FI895228A0 (fi) Integrerad optisk anordning foer maetning av brytningsindex hos vaetskan.
ATE214698T1 (de) Neue carbamazepin hapten analoge
NO903454L (no) Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav.
DK295288A (da) (1h-azol-1-ylmethyl)substituerede benzotriazolderivater
FR2616410B1 (fr) Dispositif d'atterrissage a poutre basculante
DE69232162D1 (de) Hapten-Analoge zur Verwendung in Immunoassays
FI851261L (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
DE69232002D1 (de) Immunoassays unter Verwendung von markierten Hapten-Analogen
ITPD920146A0 (it) Nuovi derivati dell'acido neuraminico
FI881413A (fi) Foerfarande foer framstaellning av 3'-azido-3'-deoxitymidin.
MC1981A1 (fr) Derives d'acides catechol carboxyliques
MC1918A1 (fr) Derives de l'imidazodiazepine
DK316589D0 (da) Substituerede azacyclohexylderivater af rifamyciner
IT1222986B (it) Derivati dell'efedrina esterificata aventi attivita' antiulcera prolungata nel tempo
DK448288D0 (da) Ethanolaminderivater
DK258988D0 (da) Individuelle isomere af endo-bicyclo(2.21)heptyladenosin
KR890701553A (ko) 시스테인의 신규 유도체
DE69232001D1 (de) Markierte Hapten-Analoge zur Verwendung in Immunoassays
IT8821135A0 (it) Derivato dell'acido ursodesossicolico.
KR890021037U (ko) 전망용 엘리베이터의 광고장치
KR890007831U (ko) 음향기기 포인타의 발광장치
IT1227695B (it) Procedimento per la reversione della tossicita' della bromovinildesossiuridina (bvudr)
BR8703239A (pt) Gerador eletronico estabilizado

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

R071 Expiry of right

Ref document number: 517325

Country of ref document: EP